RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
BMC INFECTIOUS DISEASES
Collezione ASL Città di Torino

Items : 6

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens. in BMC infectious diseases / BMC Infect Dis. 2023 Apr 14;23(1):227. doi: 10.1186/s12879-023-08191-2.

2023
ASL Città di Torino
AOU Alessandria

Di Biagio A; Bonfanti P; Falasca K; Taramasso L; Saracino A; Menzaghi B; Masiello A; Madeddu G; Bargiacchi O; Molteni C; De Socio GV; Sarchi E; Orofino G; Squillace N; Celesia BM; Vichi F; Cascio A; Pellicanò GF; Maggi P; Ricci ED; Cicalini S;

Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial. in BMC infectious diseases / BMC Infect Dis. 2022 Nov 22;22(1):879. doi: 10.1186/s12879-022-07716-5.

2022
ASL Torino 3
ASL Torino 5
AO Ordine Mauriziano
ASL Alessandria
ASL Torino 4
ASL Città di Torino
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
ASL VCO
ASL Asti
ASL Novara
ASL Cuneo 2
AOU San Luigi di Orbassano

Scozzari G; Mitola B; Benedetti V; Danielle F; Libanore V; Blangetti I; Aldieri C; Converso M; Calcagno A; Bergamo D; Berti P; Pittaluga F; Avolio M; Costa C; Raso S; Chinaglia A; Vitale F; Liccardi MM; Canta F; Russo ML; Tornello A; Maddalena L; Delios G; Baldassano S; Mattei A; De Micheli AG; Marletto FP; Russo A; Nucci A; et alii...

Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort. in BMC infectious diseases / BMC Infect Dis. 2021 May 4;21(1):413. doi: 10.1186/s12879-021-06053-3.

2021
ASL Città di Torino

Quaranta MG; Ferrigno L; Tata X; D'Angelo F; Coppola C; Ciancio A; Bruno SR; Loi M; Giorgini A; Margotti M; Cossiga V; Brancaccio G; Dallio M; De Siena M; Cannizzaro M; Cavalletto L; Massari M; Mazzitelli M; De Leo P; Laccabue D; Baiocchi L; Kondili LA;

Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study. in BMC infectious diseases / BMC Infect Dis. 2019 Jun 25;19(1):555. doi: 10.1186/s12879-019-4184-z.

2019
ASL Città di Torino

Maggi P; Santoro CR; Nofri M; Gaeta GB; De Socio GV; Bonfanti P; Molteni C; Vichi F; Francisci D; Di Biagio A; Squillace N; Menzaghi B; Orofino G; De Gennaro N; Bellacosa C; Schiaroli E; Ricci E;

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). in BMC infectious diseases / BMC Infect Dis. 2018 Jul 31;18(1):357. doi: 10.1186/s12879-018-3268-5.

2018
ASL Città di Torino
ASL VCO

Orofino G; Maggi P; Gulminetti R; Martinelli C; De Socio GV; Menzaghi B; Squillace N; Madeddu G; Ricci E; Tatarelli P; Taramasso L; Vichi F; Di Biagio A; Bonfanti P;

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data. in BMC infectious diseases / BMC Infect Dis. 2017 Sep 30;17(1):658. doi: 10.1186/s12879-017-2755-4.

2017
ASL Città di Torino

Capetti AF; Cossu MV; Orofino G; Sterrantino G; Cenderello G; De Socio GV; Cattelan AM; Soria A; Rusconi S; Riccardi N; Baldin GM; Niero FP; Barbarini G; Rizzardini G;